This video highlights trials studying the long-term impact of adjuvant tamoxifen and aromatase inhibitors for the treatment of patients with postmenopausal breast cancer.
Prudence A. Francis, MD
Advertisement
Articles by Prudence A. Francis, MD
This video reviews the impact of the SOFT/TEXT trials for the treatment of patients with premenopausal breast cancer, and ways to best use the results.
Advertisement
Latest Updated Articles
Adjuvant Endocrine Therapy in Postmenopausal Breast CancerPublished: August 25th 2017 | Updated:
Impact of SOFT/TEXT in Premenopausal Breast CancerPublished: August 25th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Subcutaneous Toripalimab Meets Primary End Points in Nonsquamous NSCLC
2
The Paradigm of AML Care: What’s New and What’s Changing
3
Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center
4
HRQOL Finds Similar Responses Between Surgery/Treatment Options in NMIBC
5
